Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| M-ESZOPICLONE | mantra pharma inc | Marketed | Dec 10, 2024 | Marketed |
| M-ESZOPICLONE | mantra pharma inc | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| M-ESZOPICLONE | mantra pharma inc | Marketed | Dec 10, 2024 | Marketed |
| BANANA BOAT ULTRA SPORT SMARTMIST SUNSCREEN SPRAY | edgewell personal care canada, ulc | Marketed | Dec 6, 2024 | Marketed |
| JAMP GATIFLOXACIN | Jamp Pharma Corporation | Marketed | Dec 5, 2024 | Marketed |
| MAR-LEFLUNOMIDE | marcan pharmaceuticals inc | Marketed | Dec 4, 2024 | Marketed |
| APO-TERIPARATIDE INJECTION | Apotex Inc | Marketed | Dec 4, 2024 | Marketed |
